查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1862157

血管生成检测：全球市场份额和排名、总收入和需求预测（2025-2031 年）

Angiogenesis Assay - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 108 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球血管生成检测市场规模预计在 2024 年达到 2,408 万美元，预计到 2031 年将达到 3,993 万美元，在 2025 年至 2031 年的预测期内，复合年增长率为 7.5%。

血管新生是一个受到严格调控的过程，在这个过程中，新的血管从已存在的血管中形成。虽然这个过程在发育和创伤治疗中具有重要的生理意义，但它也是多种疾病的通用因素，包括类风湿性关节炎、动脉粥状硬化、黄斑部病变和癌症。血管生成是在多种分子讯号的调控下发生的。通常，血管生成过程涉及内皮细胞增殖、内皮细胞趋化性地穿过细胞外基质屏障以及毛细血管管腔的形成。儘管生理性和病理性血管生成利用了许多相同的细胞过程和分子讯号网络，但病理性血管生成过程中形成的结构通常存在功能异常。

近年来，全球血管生成检测试剂盒市场保持稳定成长，主要驱动力来自肿瘤研究、心血管药物开发和类器官模型等领域的应用。依技术类型划分，体外管状结构形成实验占据主导地位，而模拟体内环境的微流体3D模型则成长最快。高端检测产品因技术壁垒而维持较高的利润率，而中国製造商正透过国内替代产品，以更低的价格（成本降低30-50%）迅速渗透中价格分布市场。按地区划分，北美是全球最大的血管生成检测试剂盒市场，占超过35%的市场。欧洲和亚太地区紧随其后，总合60%的市场份额。由于对成本高度敏感，亚太地区的本土品牌正在扩大市场份额。展望未来，随着精准医疗和抗血管生成药物开发需求的成长，高灵敏度和自动化检测方法可能成为竞争的焦点。此外，新兴市场的价格战可能会进一步加速产业整合。

本报告旨在按地区/国家、类型和应用对全球血管生成检测市场进行全面分析，重点关注总收入、市场份额和主要企业的排名。

本报告以销售收入为基准年（2024 年），对血管生成检测市场规模、估计值和预测进行了阐述，并包含了 2020 年至 2031 年的历史数据和预测数据。报告运用定量和定性分析，帮助读者制定业务和成长策略，评估市场竞争，分析自身在当前市场中的地位，并就血管生成检测做出明智的商业决策。

市场区隔

公司

  • Abcam
  • Bio-Techne（Trevigen, R&D Systems）
  • Thermo Fisher Scientific
  • Cell Biolabs, Inc.
  • BioVision, Inc
  • PromoCell GmbH
  • Merck KGaA
  • Kollodis BioSciences
  • Sartorius（Essen BioScience）
  • Creative Bioarray
  • ibidi GmbH
  • Solarbio

按类型分類的细分市场

  • 体外检测试剂盒
  • 体内检测试剂盒

应用领域

  • 学术机构
  • 生技公司

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Angiogenesis Assay was estimated to be worth US$ 24.08 million in 2024 and is forecast to a readjusted size of US$ 39.93 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.

Angiogenesis is the tightly regulated process by which new blood vessels are formed from the existing vasculature. This process is physiologically important for development and wound healing, and is also a common driver in multiple diseases including rheumatoid arthritis, atherosclerosis, macular degeneration, and cancer. Angiogenesis occurs in response to a variety of molecular cues. Generally, the angiogenic process includes endothelial cell proliferation, chemotactic endothelial cell migration through the extracellular matrix barrier, and the formation of capillary tubes. Physiological and pathological angiogenesis utilize many of the same cellular processes and molecular signaling networks, however the structures that form during pathological angiogenesis are often functionally abnormal.

The global angiogenesis assay kit market has maintained steady growth in recent years, primarily driven by applications in oncology research, cardiovascular drug development, and organoid models. In terms of technology type, in vitro tube formation experiments dominate, while microfluidic 3D models, embracing the in vivo environment, are experiencing the fastest growth. Regarding pricing, high-end assays maintain high margins thanks to technological barriers, while Chinese manufacturers are rapidly penetrating the mid- and low-end markets through domestic substitution (reducing prices by 30%-50%). Regionally, North America is the largest global market for angiogenesis assay kits, holding over 35% of the market share, followed by Europe and Asia Pacific, which together hold nearly 60% of the market share. Due to cost sensitivity, the Asia Pacific market is seeing an increase in the share of local brands. In the future, as demand for precision medicine and anti-angiogenic drug development increases, highly sensitive, automated assays will become a key competitive focus. Furthermore, price competition in emerging markets is likely to further intensify industry consolidation.

This report aims to provide a comprehensive presentation of the global market for Angiogenesis Assay, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Angiogenesis Assay by region & country, by Type, and by Application.

The Angiogenesis Assay market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiogenesis Assay.

Market Segmentation

By Company

  • Abcam
  • Bio-Techne (Trevigen, R&D Systems)
  • Thermo Fisher Scientific
  • Cell Biolabs, Inc.
  • BioVision, Inc
  • PromoCell GmbH
  • Merck KGaA
  • Kollodis BioSciences
  • Sartorius (Essen BioScience)
  • Creative Bioarray
  • ibidi GmbH
  • Solarbio

Segment by Type

  • In Vitro Assay Kit
  • In Vivo Assay Kit

Segment by Application

  • Academic Institution
  • Biotech Companies

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Angiogenesis Assay company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Angiogenesis Assay in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Angiogenesis Assay in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Angiogenesis Assay Product Introduction
  • 1.2 Global Angiogenesis Assay Market Size Forecast (2020-2031)
  • 1.3 Angiogenesis Assay Market Trends & Drivers
    • 1.3.1 Angiogenesis Assay Industry Trends
    • 1.3.2 Angiogenesis Assay Market Drivers & Opportunity
    • 1.3.3 Angiogenesis Assay Market Challenges
    • 1.3.4 Angiogenesis Assay Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Angiogenesis Assay Players Revenue Ranking (2024)
  • 2.2 Global Angiogenesis Assay Revenue by Company (2020-2025)
  • 2.3 Key Companies Angiogenesis Assay Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Angiogenesis Assay Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Angiogenesis Assay
  • 2.6 Angiogenesis Assay Market Competitive Analysis
    • 2.6.1 Angiogenesis Assay Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Angiogenesis Assay Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiogenesis Assay as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 In Vitro Assay Kit
    • 3.1.2 In Vivo Assay Kit
  • 3.2 Global Angiogenesis Assay Sales Value by Type
    • 3.2.1 Global Angiogenesis Assay Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Angiogenesis Assay Sales Value, by Type (2020-2031)
    • 3.2.3 Global Angiogenesis Assay Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Academic Institution
    • 4.1.2 Biotech Companies
  • 4.2 Global Angiogenesis Assay Sales Value by Application
    • 4.2.1 Global Angiogenesis Assay Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Angiogenesis Assay Sales Value, by Application (2020-2031)
    • 4.2.3 Global Angiogenesis Assay Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Angiogenesis Assay Sales Value by Region
    • 5.1.1 Global Angiogenesis Assay Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Angiogenesis Assay Sales Value by Region (2020-2025)
    • 5.1.3 Global Angiogenesis Assay Sales Value by Region (2026-2031)
    • 5.1.4 Global Angiogenesis Assay Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Angiogenesis Assay Sales Value, 2020-2031
    • 5.2.2 North America Angiogenesis Assay Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Angiogenesis Assay Sales Value, 2020-2031
    • 5.3.2 Europe Angiogenesis Assay Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Angiogenesis Assay Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Angiogenesis Assay Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Angiogenesis Assay Sales Value, 2020-2031
    • 5.5.2 South America Angiogenesis Assay Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Angiogenesis Assay Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Angiogenesis Assay Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Angiogenesis Assay Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Angiogenesis Assay Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Angiogenesis Assay Sales Value, 2020-2031
    • 6.3.2 United States Angiogenesis Assay Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Angiogenesis Assay Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Angiogenesis Assay Sales Value, 2020-2031
    • 6.4.2 Europe Angiogenesis Assay Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Angiogenesis Assay Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Angiogenesis Assay Sales Value, 2020-2031
    • 6.5.2 China Angiogenesis Assay Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Angiogenesis Assay Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Angiogenesis Assay Sales Value, 2020-2031
    • 6.6.2 Japan Angiogenesis Assay Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Angiogenesis Assay Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Angiogenesis Assay Sales Value, 2020-2031
    • 6.7.2 South Korea Angiogenesis Assay Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Angiogenesis Assay Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Angiogenesis Assay Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Angiogenesis Assay Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Angiogenesis Assay Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Angiogenesis Assay Sales Value, 2020-2031
    • 6.9.2 India Angiogenesis Assay Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Angiogenesis Assay Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Abcam
    • 7.1.1 Abcam Profile
    • 7.1.2 Abcam Main Business
    • 7.1.3 Abcam Angiogenesis Assay Products, Services and Solutions
    • 7.1.4 Abcam Angiogenesis Assay Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Abcam Recent Developments
  • 7.2 Bio-Techne (Trevigen, R&D Systems)
    • 7.2.1 Bio-Techne (Trevigen, R&D Systems) Profile
    • 7.2.2 Bio-Techne (Trevigen, R&D Systems) Main Business
    • 7.2.3 Bio-Techne (Trevigen, R&D Systems) Angiogenesis Assay Products, Services and Solutions
    • 7.2.4 Bio-Techne (Trevigen, R&D Systems) Angiogenesis Assay Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Bio-Techne (Trevigen, R&D Systems) Recent Developments
  • 7.3 Thermo Fisher Scientific
    • 7.3.1 Thermo Fisher Scientific Profile
    • 7.3.2 Thermo Fisher Scientific Main Business
    • 7.3.3 Thermo Fisher Scientific Angiogenesis Assay Products, Services and Solutions
    • 7.3.4 Thermo Fisher Scientific Angiogenesis Assay Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Thermo Fisher Scientific Recent Developments
  • 7.4 Cell Biolabs, Inc.
    • 7.4.1 Cell Biolabs, Inc. Profile
    • 7.4.2 Cell Biolabs, Inc. Main Business
    • 7.4.3 Cell Biolabs, Inc. Angiogenesis Assay Products, Services and Solutions
    • 7.4.4 Cell Biolabs, Inc. Angiogenesis Assay Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Cell Biolabs, Inc. Recent Developments
  • 7.5 BioVision, Inc
    • 7.5.1 BioVision, Inc Profile
    • 7.5.2 BioVision, Inc Main Business
    • 7.5.3 BioVision, Inc Angiogenesis Assay Products, Services and Solutions
    • 7.5.4 BioVision, Inc Angiogenesis Assay Revenue (US$ Million) & (2020-2025)
    • 7.5.5 BioVision, Inc Recent Developments
  • 7.6 PromoCell GmbH
    • 7.6.1 PromoCell GmbH Profile
    • 7.6.2 PromoCell GmbH Main Business
    • 7.6.3 PromoCell GmbH Angiogenesis Assay Products, Services and Solutions
    • 7.6.4 PromoCell GmbH Angiogenesis Assay Revenue (US$ Million) & (2020-2025)
    • 7.6.5 PromoCell GmbH Recent Developments
  • 7.7 Merck KGaA
    • 7.7.1 Merck KGaA Profile
    • 7.7.2 Merck KGaA Main Business
    • 7.7.3 Merck KGaA Angiogenesis Assay Products, Services and Solutions
    • 7.7.4 Merck KGaA Angiogenesis Assay Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Merck KGaA Recent Developments
  • 7.8 Kollodis BioSciences
    • 7.8.1 Kollodis BioSciences Profile
    • 7.8.2 Kollodis BioSciences Main Business
    • 7.8.3 Kollodis BioSciences Angiogenesis Assay Products, Services and Solutions
    • 7.8.4 Kollodis BioSciences Angiogenesis Assay Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Kollodis BioSciences Recent Developments
  • 7.9 Sartorius (Essen BioScience)
    • 7.9.1 Sartorius (Essen BioScience) Profile
    • 7.9.2 Sartorius (Essen BioScience) Main Business
    • 7.9.3 Sartorius (Essen BioScience) Angiogenesis Assay Products, Services and Solutions
    • 7.9.4 Sartorius (Essen BioScience) Angiogenesis Assay Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Sartorius (Essen BioScience) Recent Developments
  • 7.10 Creative Bioarray
    • 7.10.1 Creative Bioarray Profile
    • 7.10.2 Creative Bioarray Main Business
    • 7.10.3 Creative Bioarray Angiogenesis Assay Products, Services and Solutions
    • 7.10.4 Creative Bioarray Angiogenesis Assay Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Creative Bioarray Recent Developments
  • 7.11 ibidi GmbH
    • 7.11.1 ibidi GmbH Profile
    • 7.11.2 ibidi GmbH Main Business
    • 7.11.3 ibidi GmbH Angiogenesis Assay Products, Services and Solutions
    • 7.11.4 ibidi GmbH Angiogenesis Assay Revenue (US$ Million) & (2020-2025)
    • 7.11.5 ibidi GmbH Recent Developments
  • 7.12 Solarbio
    • 7.12.1 Solarbio Profile
    • 7.12.2 Solarbio Main Business
    • 7.12.3 Solarbio Angiogenesis Assay Products, Services and Solutions
    • 7.12.4 Solarbio Angiogenesis Assay Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Solarbio Recent Developments

8 Industry Chain Analysis

  • 8.1 Angiogenesis Assay Industrial Chain
  • 8.2 Angiogenesis Assay Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Angiogenesis Assay Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Angiogenesis Assay Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Angiogenesis Assay Market Trends
  • Table 2. Angiogenesis Assay Market Drivers & Opportunity
  • Table 3. Angiogenesis Assay Market Challenges
  • Table 4. Angiogenesis Assay Market Restraints
  • Table 5. Global Angiogenesis Assay Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Angiogenesis Assay Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Angiogenesis Assay Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Angiogenesis Assay Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Angiogenesis Assay
  • Table 10. Global Angiogenesis Assay Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiogenesis Assay as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Angiogenesis Assay Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Angiogenesis Assay Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Angiogenesis Assay Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Angiogenesis Assay Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Angiogenesis Assay Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Angiogenesis Assay Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Angiogenesis Assay Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Angiogenesis Assay Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Angiogenesis Assay Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Angiogenesis Assay Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Angiogenesis Assay Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Angiogenesis Assay Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Angiogenesis Assay Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Angiogenesis Assay Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Angiogenesis Assay Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Angiogenesis Assay Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Angiogenesis Assay Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Angiogenesis Assay Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Abcam Basic Information List
  • Table 32. Abcam Description and Business Overview
  • Table 33. Abcam Angiogenesis Assay Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Angiogenesis Assay Business of Abcam (2020-2025)
  • Table 35. Abcam Recent Developments
  • Table 36. Bio-Techne (Trevigen, R&D Systems) Basic Information List
  • Table 37. Bio-Techne (Trevigen, R&D Systems) Description and Business Overview
  • Table 38. Bio-Techne (Trevigen, R&D Systems) Angiogenesis Assay Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Angiogenesis Assay Business of Bio-Techne (Trevigen, R&D Systems) (2020-2025)
  • Table 40. Bio-Techne (Trevigen, R&D Systems) Recent Developments
  • Table 41. Thermo Fisher Scientific Basic Information List
  • Table 42. Thermo Fisher Scientific Description and Business Overview
  • Table 43. Thermo Fisher Scientific Angiogenesis Assay Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Angiogenesis Assay Business of Thermo Fisher Scientific (2020-2025)
  • Table 45. Thermo Fisher Scientific Recent Developments
  • Table 46. Cell Biolabs, Inc. Basic Information List
  • Table 47. Cell Biolabs, Inc. Description and Business Overview
  • Table 48. Cell Biolabs, Inc. Angiogenesis Assay Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Angiogenesis Assay Business of Cell Biolabs, Inc. (2020-2025)
  • Table 50. Cell Biolabs, Inc. Recent Developments
  • Table 51. BioVision, Inc Basic Information List
  • Table 52. BioVision, Inc Description and Business Overview
  • Table 53. BioVision, Inc Angiogenesis Assay Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Angiogenesis Assay Business of BioVision, Inc (2020-2025)
  • Table 55. BioVision, Inc Recent Developments
  • Table 56. PromoCell GmbH Basic Information List
  • Table 57. PromoCell GmbH Description and Business Overview
  • Table 58. PromoCell GmbH Angiogenesis Assay Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Angiogenesis Assay Business of PromoCell GmbH (2020-2025)
  • Table 60. PromoCell GmbH Recent Developments
  • Table 61. Merck KGaA Basic Information List
  • Table 62. Merck KGaA Description and Business Overview
  • Table 63. Merck KGaA Angiogenesis Assay Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Angiogenesis Assay Business of Merck KGaA (2020-2025)
  • Table 65. Merck KGaA Recent Developments
  • Table 66. Kollodis BioSciences Basic Information List
  • Table 67. Kollodis BioSciences Description and Business Overview
  • Table 68. Kollodis BioSciences Angiogenesis Assay Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Angiogenesis Assay Business of Kollodis BioSciences (2020-2025)
  • Table 70. Kollodis BioSciences Recent Developments
  • Table 71. Sartorius (Essen BioScience) Basic Information List
  • Table 72. Sartorius (Essen BioScience) Description and Business Overview
  • Table 73. Sartorius (Essen BioScience) Angiogenesis Assay Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Angiogenesis Assay Business of Sartorius (Essen BioScience) (2020-2025)
  • Table 75. Sartorius (Essen BioScience) Recent Developments
  • Table 76. Creative Bioarray Basic Information List
  • Table 77. Creative Bioarray Description and Business Overview
  • Table 78. Creative Bioarray Angiogenesis Assay Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Angiogenesis Assay Business of Creative Bioarray (2020-2025)
  • Table 80. Creative Bioarray Recent Developments
  • Table 81. ibidi GmbH Basic Information List
  • Table 82. ibidi GmbH Description and Business Overview
  • Table 83. ibidi GmbH Angiogenesis Assay Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Angiogenesis Assay Business of ibidi GmbH (2020-2025)
  • Table 85. ibidi GmbH Recent Developments
  • Table 86. Solarbio Basic Information List
  • Table 87. Solarbio Description and Business Overview
  • Table 88. Solarbio Angiogenesis Assay Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Angiogenesis Assay Business of Solarbio (2020-2025)
  • Table 90. Solarbio Recent Developments
  • Table 91. Key Raw Materials Lists
  • Table 92. Raw Materials Key Suppliers Lists
  • Table 93. Angiogenesis Assay Downstream Customers
  • Table 94. Angiogenesis Assay Distributors List
  • Table 95. Research Programs/Design for This Report
  • Table 96. Key Data Information from Secondary Sources
  • Table 97. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Angiogenesis Assay Product Picture
  • Figure 2. Global Angiogenesis Assay Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Angiogenesis Assay Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Angiogenesis Assay Report Years Considered
  • Figure 5. Global Angiogenesis Assay Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Angiogenesis Assay Revenue in 2024
  • Figure 7. Angiogenesis Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. In Vitro Assay Kit Picture
  • Figure 9. In Vivo Assay Kit Picture
  • Figure 10. Global Angiogenesis Assay Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 11. Global Angiogenesis Assay Sales Value Market Share by Type, 2024 & 2031
  • Figure 12. Product Picture of Academic Institution
  • Figure 13. Product Picture of Biotech Companies
  • Figure 14. Global Angiogenesis Assay Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 15. Global Angiogenesis Assay Sales Value Market Share by Application, 2024 & 2031
  • Figure 16. North America Angiogenesis Assay Sales Value (2020-2031) & (US$ Million)
  • Figure 17. North America Angiogenesis Assay Sales Value by Country (%), 2024 VS 2031
  • Figure 18. Europe Angiogenesis Assay Sales Value, (2020-2031) & (US$ Million)
  • Figure 19. Europe Angiogenesis Assay Sales Value by Country (%), 2024 VS 2031
  • Figure 20. Asia Pacific Angiogenesis Assay Sales Value, (2020-2031) & (US$ Million)
  • Figure 21. Asia Pacific Angiogenesis Assay Sales Value by Region (%), 2024 VS 2031
  • Figure 22. South America Angiogenesis Assay Sales Value, (2020-2031) & (US$ Million)
  • Figure 23. South America Angiogenesis Assay Sales Value by Country (%), 2024 VS 2031
  • Figure 24. Middle East & Africa Angiogenesis Assay Sales Value, (2020-2031) & (US$ Million)
  • Figure 25. Middle East & Africa Angiogenesis Assay Sales Value by Country (%), 2024 VS 2031
  • Figure 26. Key Countries/Regions Angiogenesis Assay Sales Value (%), (2020-2031)
  • Figure 27. United States Angiogenesis Assay Sales Value, (2020-2031) & (US$ Million)
  • Figure 28. United States Angiogenesis Assay Sales Value by Type (%), 2024 VS 2031
  • Figure 29. United States Angiogenesis Assay Sales Value by Application (%), 2024 VS 2031
  • Figure 30. Europe Angiogenesis Assay Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Europe Angiogenesis Assay Sales Value by Type (%), 2024 VS 2031
  • Figure 32. Europe Angiogenesis Assay Sales Value by Application (%), 2024 VS 2031
  • Figure 33. China Angiogenesis Assay Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. China Angiogenesis Assay Sales Value by Type (%), 2024 VS 2031
  • Figure 35. China Angiogenesis Assay Sales Value by Application (%), 2024 VS 2031
  • Figure 36. Japan Angiogenesis Assay Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. Japan Angiogenesis Assay Sales Value by Type (%), 2024 VS 2031
  • Figure 38. Japan Angiogenesis Assay Sales Value by Application (%), 2024 VS 2031
  • Figure 39. South Korea Angiogenesis Assay Sales Value, (2020-2031) & (US$ Million)
  • Figure 40. South Korea Angiogenesis Assay Sales Value by Type (%), 2024 VS 2031
  • Figure 41. South Korea Angiogenesis Assay Sales Value by Application (%), 2024 VS 2031
  • Figure 42. Southeast Asia Angiogenesis Assay Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. Southeast Asia Angiogenesis Assay Sales Value by Type (%), 2024 VS 2031
  • Figure 44. Southeast Asia Angiogenesis Assay Sales Value by Application (%), 2024 VS 2031
  • Figure 45. India Angiogenesis Assay Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. India Angiogenesis Assay Sales Value by Type (%), 2024 VS 2031
  • Figure 47. India Angiogenesis Assay Sales Value by Application (%), 2024 VS 2031
  • Figure 48. Angiogenesis Assay Industrial Chain
  • Figure 49. Angiogenesis Assay Manufacturing Cost Structure
  • Figure 50. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 51. Bottom-up and Top-down Approaches for This Report
  • Figure 52. Data Triangulation
  • Figure 53. Key Executives Interviewed